.alpha.-glucosidase inhibitors
US5157116A · kind A · utility
14Cited by
7References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 1992 |
| Grant date | Oct 20, 1992 |
| Priority date | — |
| Expiry date | Feb 18, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/048
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to novel N-derivatives of 1-deoxy-nojirimycin, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.